{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-24-011545","form_type":"8-K","ticker":"CLNN","cik":"0001822791","company_name":"Clene Inc.","filed_at":"2024-04-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:20.400543+00:00","generated_at":"2026-06-04T01:05:13.288694+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Clene enters $7.3M subaward with Columbia University for NIH-funded ALS Expanded Access Program","bullets":["Clene Nanomedicine signed subaward for up to $7.3M for initial phase of NIH grant supporting CNM-Au8 EAP in ALS.","Total subaward potential under $45.1M NIH grant could reach $30.9M through August 2027.","Funds reimburse expenses from Sept 25, 2023 to Aug 31, 2024; invoiced monthly or quarterly.","Agreement protects Clene's background IP; no license granted to Columbia or US Government.","Either party may terminate with 30 days' notice; termination required if NIH terminates grant."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-24-011545","json":"https://secwatch.observer/filing/0001437749-24-011545.json","markdown":"https://secwatch.observer/filing/0001437749-24-011545.md","text":"https://secwatch.observer/filing/0001437749-24-011545.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1822791/000143774924011545/0001437749-24-011545-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1822791/000143774924011545/clnn20240409_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T01:05:13.288694+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"88278cc1f54e8dc0b947c7efdf1efdd02464b8c4","claim":"Clene Inc. entered into Subaward with Colombia University valued at up to $7.3 million (effective 2024-04-03).","evidence_excerpt":"On April 3, 2024, the Company entered into a grant subaward agreement (the “Subaward”) with Colombia pursuant to the NIH Grant.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1822791/000143774924011545/0001437749-24-011545-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Counterparty","value":"Colombia University"},{"label":"Value","value":"up to $7.3 million"},{"label":"Effective","value":"2024-04-03"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}